Metabolic syndrome and disability: findings from the prospective three-city study.: Metabolic Syndrome and disability

Autor: Isabelle Carrière, Claudine Berr, Véronique Gourlet, Tasnime N. Akbaraly, Pascale Barberger-Gateau, Kim Bouillon, Karen Ritchie, Mika Kivimäki, Marie-Laure Ancelin, Karine Pérès

Publikováno v: Journals of Gerontology, Series A
Journals of Gerontology, Series A, Oxford University Press (OUP): Policy B-Oxford Open Option D, 2014, 69 (1), pp.79-86. ⟨10.1093/gerona/glt101⟩
Journals of Gerontology Series A: Biological Sciences and Medical Sciences
Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2014, 69 (1), pp.79-86. ⟨10.1093/gerona/glt101⟩

International audience; BACKGROUND: Metabolic syndrome (MetS) is a potentially reversible cause of disability in the elderly people. The published literature suggests that the MetS-disability association is likely to be complex, depending on co-exist

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c0adba575e9c3cda141b193876bc01c
https://doi.org/10.1093/gerona/glt101

C reactive protein and its determinants in healthy men and women from European regions at different risk of coronary disease: the IMMIDIET Project

Autor: Arcari, A, Zito, F, Di Castelnuovo, A, De Curtis, A, Dirckx, C, Arnout, J, Cappuccio, Fp, van Dongen MC, De Lorgeril, M, Krogh, V, Siani, A, Donati, Mb, De Gaetano, G, Iacoviello, Licia, European Collaborative Group of Immidiet Project

Publikováno v: Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis, Wiley, 2008, 6 (3), pp.436-43. ⟨10.1111/j.1538-7836.2007.02851.x⟩
Journal of Thrombosis and Haemostasis, 6(3), 436-43. Wiley
Journal of thrombosis and haemostasis
6 (2008): 436–443. doi:10.1111/j.1538-7836.2007.02851.x
info:cnr-pdr/source/autori:Arcari A; Zito F; Di Castelnuovo A; De Curtis A; Dirckx C; Arnout J; Cappuccio FP; van Dongen MC; De Lorgeril M; Krogh V; Siani A; Donati MB; De Gaetano G; Iacoviello L; European Collaborative Group of Immidiet Project./titolo:C reactive protein and its determinants in healthy men and women from European regions at different risk of coronary disease: the IMMIDIET Project./doi:10.1111%2Fj.1538-7836.2007.02851.x/rivista:Journal of thrombosis and haemostasis (Print)/anno:2008/pagina_da:436/pagina_a:443/intervallo_pagine:436–443/volume:6

International audience; AIM: Differences in C-reactive protein (CRP) levels and its determinants in three European populations at different risk of coronary artery disease (CAD) were studied. METHODS: Subjects were recruited randomly in Limburg (Belg

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea8f7c4d94c6fa406a6d0b7131d37595
https://doi.org/10.1111/j.1538-7836.2007.02851.x

Weight change and changes in the metabolic syndrome as the French population moves towards overweight: The D.E.S.I.R. Cohort

Autor: Anne Fagot-Campagna, M. Cailleau, Sylviane Vol, Beverley Balkau, Eveline Eschwège, Teresa A. Hillier

Publikováno v: International Journal of Epidemiology
International Journal of Epidemiology, Oxford University Press (OUP), 2006, 35 (1), pp.190-6. ⟨10.1093/ije/dyi281⟩

International audience; BACKGROUND: How weight change affects the metabolic syndrome (MS) and its parameters is unknown, particularly, in a leaner European population such as the French prospective D.E.S.I.R. cohort. METHODS: In 3770 D.E.S.I.R. parti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45a78a892d620f91166c384212065327
https://doi.org/10.1093/ije/dyi281

Pro-inflammatory phospholipid arachidonic acid/eicosapentaenoic acid ratio of dysmetabolic severely obese women

Autor: A. Fioroni, Picard Marceau, Anne Galinier, M. C. Pujol, Pascale Mauriège, Isabelle Lemieux, Luc Pénicaud, Denis Richard, Sylvie Allenbach, Robert Salvayre, Louis Casteilla, Sylvie Caspar-Bauguil, Amélie Cartier, Simon Biron

Publikováno v: Obesity Surgery
Obesity Surgery, Springer Verlag, 2012, 22 (6), pp.935-44. ⟨10.1007/s11695-012-0633-0⟩
Obesity Surgery, Springer Verlag, 2012, 22 (6), pp.935-44. 〈10.1007/s11695-012-0633-0〉

International audience; BACKGROUND: Fatty acids (FAs) and adipokines such as adiponectin or interleukin-6 (IL-6) are known to modulate inflammation and the development of metabolic syndrome. Whether FA composition assessed in plasma triacylglycerols

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40526033374df44deaead5df61509885
https://hal.archives-ouvertes.fr/hal-00725155

Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity

Autor: Juliana A. de Souza, Carlos V. Serrano, Anatol Kontush, M. John Chapman, Anne Nègre-Salvayre, S. Chantepie, Cécile Vindis, Robert Salvayre, Boris Hansel, P. Thérond, Eric Bruckert

Publikováno v: Atherosclerosis
Atherosclerosis, 2008, 197 (1), pp.84-94. ⟨10.1016/j.atherosclerosis.2007.08.009⟩
Atherosclerosis, Elsevier, 2008, 197 (1), pp.84-94. ⟨10.1016/j.atherosclerosis.2007.08.009⟩
Atherosclerosis, Elsevier, 2008, 197 (1), pp.84-94. 〈10.1016/j.atherosclerosis.2007.08.009〉

International audience; The metabolic syndrome (MetS) phenotype is typically characterized by visceral obesity, insulin resistance, atherogenic dyslipidemia involving hypertriglyceridemia and subnormal levels of high density lipoprotein-cholesterol (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07e30584b450b5471719a79073ef1314
https://www.hal.inserm.fr/inserm-00408921